Home › Funds › Legion Partners Asset Management, LLC › LFCR
Legion Partners Asset Management, LLC position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
Legion Partners Asset Management, LLC reported holding 4,481,329 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$29.5M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. Legion Partners Asset Management, LLC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Legion Partners Asset Management, LLC's LFCR position evolved
Legion Partners Asset Management, LLC first disclosed a stake in LFCR in Q3 2023 at 2,940,340 shares (US$22.2M). The position peaked in Q4 2025 at 4,461,823 shares, worth US$36.5M. Across 13 filings, Legion Partners Asset Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 4,481,329 shares valued at US$29.5M. Notable position changes include a 49% increase in Q4 2024 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.94M | $22.18M | New |
| Q4 2023 | 2.94M | $18.20M | Hold |
| Q1 2024 | 2.95M | $15.67M | Hold |
| Q2 2024 | 2.97M | $15.23M | Add |
| Q3 2024 | 2.97M | $14.63M | Hold |
| Q4 2024 | 4.43M | $32.93M | Add |
| Q1 2025 | 4.43M | $31.20M | Hold |
| Q2 2025 | 4.43M | $35.99M | Hold |
| Q3 2025 | 4.46M | $32.84M | Add |
| Q4 2025 | 4.46M | $36.50M | Hold |
| Q1 2026 | 4.46M | $16.60M | Hold |
| Q2 2026 | 4.46M | $23.42M | Hold |
| Q3 2026 | 4.48M | $29.49M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 23 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$32.0M), 325 CAPITAL LLC (US$19.1M), Greenhaven Road Investment Management, L.P. (US$18.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.87M sh · $32.03M · Q3 2026
- 325 CAPITAL LLC 2.90M sh · $19.05M · Q3 2026
- Greenhaven Road Investment Management, L.P. 2.87M sh · $18.88M · Q3 2026
- DCF Advisers, LLC 376.50K sh · $2.48M · Q3 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 305.31K sh · $2.01M · Q3 2026
More on Legion Partners Asset Management, LLC
FAQ
How long has Legion Partners Asset Management, LLC held LFCR?
Legion Partners Asset Management, LLC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Legion Partners Asset Management, LLC's current position in LFCR?
As of Q3 2026, Legion Partners Asset Management, LLC holds 4.48M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $29.49M, representing 100.00% of its reported portfolio and ranking #1.
Has Legion Partners Asset Management, LLC been buying or selling LFCR?
In the latest 13F filing (Q3 2026), Legion Partners Asset Management, LLC held unchanged its position in LFCR. The position peaked in Q4 2025 at 4.46M shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, 325 CAPITAL LLC, Greenhaven Road Investment Management, L.P., among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.